Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan

Detalles Bibliográficos
Autores principales: Koda, Masahide, Iwasaki, Motoki, Yamano, Yuko, Lu, Xi, Katoh, Takahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033284/
https://www.ncbi.nlm.nih.gov/pubmed/29973138
http://dx.doi.org/10.1186/s12199-018-0718-z
_version_ 1783337674326671360
author Koda, Masahide
Iwasaki, Motoki
Yamano, Yuko
Lu, Xi
Katoh, Takahiko
author_facet Koda, Masahide
Iwasaki, Motoki
Yamano, Yuko
Lu, Xi
Katoh, Takahiko
author_sort Koda, Masahide
collection PubMed
description
format Online
Article
Text
id pubmed-6033284
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60332842018-07-12 Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan Koda, Masahide Iwasaki, Motoki Yamano, Yuko Lu, Xi Katoh, Takahiko Environ Health Prev Med Correction BioMed Central 2018-07-04 2018 /pmc/articles/PMC6033284/ /pubmed/29973138 http://dx.doi.org/10.1186/s12199-018-0718-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Koda, Masahide
Iwasaki, Motoki
Yamano, Yuko
Lu, Xi
Katoh, Takahiko
Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
title Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
title_full Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
title_fullStr Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
title_full_unstemmed Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
title_short Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
title_sort correction to: association between nat2, cyp1a1, and cyp1a2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in japan
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033284/
https://www.ncbi.nlm.nih.gov/pubmed/29973138
http://dx.doi.org/10.1186/s12199-018-0718-z
work_keys_str_mv AT kodamasahide correctiontoassociationbetweennat2cyp1a1andcyp1a2genotypesheterocyclicaromaticaminesandprostatecancerriskacasecontrolstudyinjapan
AT iwasakimotoki correctiontoassociationbetweennat2cyp1a1andcyp1a2genotypesheterocyclicaromaticaminesandprostatecancerriskacasecontrolstudyinjapan
AT yamanoyuko correctiontoassociationbetweennat2cyp1a1andcyp1a2genotypesheterocyclicaromaticaminesandprostatecancerriskacasecontrolstudyinjapan
AT luxi correctiontoassociationbetweennat2cyp1a1andcyp1a2genotypesheterocyclicaromaticaminesandprostatecancerriskacasecontrolstudyinjapan
AT katohtakahiko correctiontoassociationbetweennat2cyp1a1andcyp1a2genotypesheterocyclicaromaticaminesandprostatecancerriskacasecontrolstudyinjapan

Ejemplares similares